1. To become acquainted with the diagnostic criteria for a newly recognized clinical entity: clonal hematopoiesis of indeterminate potential (CHIP).

   2. To understand the relationship between somatic mutations in bone marrow stem cells and the generation of clones of mutated leukocytes in peripheral blood.

   3. To learn of the newly recognized links between clonal hematopoiesis and risk of myocardial infarction, stroke, and heart failure events.



Session date: 
05/31/2019 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Peter Libby, MD